Insufficient scRNA-seq data for expression of BSND at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 1302.39 | 89 / 89 | 12% | 3.69 | 104 / 901 |
spleen | 79% | 25.26 | 191 / 241 | 0% | 0 | 0 / 0 |
brain | 57% | 26.11 | 1512 / 2642 | 0% | 0 | 0 / 705 |
prostate | 46% | 6.92 | 113 / 245 | 0% | 0.01 | 1 / 502 |
lung | 40% | 4.85 | 230 / 578 | 1% | 0.02 | 9 / 1155 |
peripheral blood | 38% | 19.21 | 349 / 929 | 0% | 0 | 0 / 0 |
breast | 28% | 6.28 | 127 / 459 | 0% | 0.01 | 4 / 1118 |
skin | 26% | 2.70 | 464 / 1809 | 0% | 0.06 | 1 / 472 |
adrenal gland | 20% | 2.13 | 51 / 258 | 0% | 0 | 0 / 230 |
blood vessel | 12% | 1.60 | 161 / 1335 | 0% | 0 | 0 / 0 |
ovary | 4% | 0.34 | 8 / 180 | 7% | 0.15 | 32 / 430 |
intestine | 10% | 1.36 | 99 / 966 | 0% | 0.00 | 1 / 527 |
pancreas | 10% | 0.81 | 33 / 328 | 0% | 0 | 0 / 178 |
stomach | 7% | 0.62 | 24 / 359 | 1% | 0.05 | 2 / 286 |
thymus | 6% | 0.72 | 42 / 653 | 0% | 0.01 | 2 / 605 |
adipose | 7% | 0.57 | 81 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 6% | 0.49 | 82 / 1445 | 0% | 0 | 0 / 183 |
uterus | 4% | 1.42 | 6 / 170 | 1% | 0.04 | 3 / 459 |
liver | 3% | 0.26 | 6 / 226 | 0% | 0.00 | 1 / 406 |
muscle | 2% | 0.25 | 13 / 803 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 1% | 0.07 | 4 / 504 |
heart | 0% | 0.02 | 3 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1902476 | Biological process | chloride transmembrane transport |
GO_0006821 | Biological process | chloride transport |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0017081 | Molecular function | chloride channel regulator activity |
GO_0005515 | Molecular function | protein binding |
GO_0005254 | Molecular function | chloride channel activity |
Gene name | BSND |
Protein name | Bartter syndrome, infantile, with sensorineural deafness (Barttin) Barttin |
Synonyms | BART hCG_33039 |
Description | FUNCTION: Functions as a beta-subunit for CLCNKA and CLCNKB chloride channels. In the kidney CLCNK/BSND heteromers mediate chloride reabsorption by facilitating its basolateral efflux. In the stria, CLCNK/BSND channels drive potassium secretion by recycling chloride for the basolateral SLC12A2 cotransporter. . |
Accessions | Q8WZ55 Q5VU50 ENST00000651561.1 |